As such, a number of S1PR1-specific modulators (agonists and antagonists) and modulators that target multiple S1PRs that include S1PR1, have been designed that have potential as cancer therapies [8], however only a couple have made it into cancer clinical trials, reviewed in [8,12]. This evidence concerns the gene S1PR1 and cancer.